Using quantitative real time PCR and immunohistochemistry [11], presented data showed that WT1 is not only highly expressed in leukaemia but also in a variety of nonhaematopoetic malignancies including lung cancer, colon cancer and pancreatic carcinomas. Here, WT1 is linked to leukemia.